Document is current

Any future updates will be listed below

1245 Evaluating the efficacy of targeted therapies in HER2-driven cancers using patient-derived xenograft organoids

Crossref DOI link: https://doi.org/10.1136/jitc-2025-SITC2025.1245

Published Online: 2025-11-04

Published Print: 2025-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark